Search

everythinglearnresearchcommunity

for

Search:↓

Managing skin diseases during pregnancy and postpartum requires careful consideration of treatment safety and dosing to protect both mother and baby.

Leflunomide successfully treated a rare skin condition in a liver transplant patient.

The combination therapy was effective and well-tolerated, especially in young patients.

A man's skin condition, pemphigus vulgaris, came back after he was treated with interleukin 2 for cancer.

Certain leukemia drugs can cause severe skin reactions that may require stopping treatment.

Pregnant women often experience a variety of skin problems, including pigmentation changes and stretch marks.

Majoon Ushba and Marham Gulabi effectively treat dermatophytosis.

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

Pregnancy can cause various skin changes and diseases, with PUPPP being the most common skin condition specific to pregnancy.

A child's rare skin disease was triggered by chickenpox.

Restoring phenylalanine levels improved skin and hair symptoms in a PKU infant.

Dupilumab helped an 11-year-old boy regrow hair and reduce skin rashes.

Skin symptoms are common in lupus patients in Antananarivo.

Anti-Desmocollin 3 antibodies can cause atypical pemphigus symptoms.

Tofacitinib may help hair regrowth in familial alopecia areata with immune issues, but more research is needed.

Pregnancy-related skin disorders need accurate diagnosis and treatment to prevent risks to the baby.

Early recognition of skin issues in immunocompromised patients is crucial for better outcomes.

A three-year-old girl survived a rare serious infection caused by BCG vaccination, which improved after treatment with a leprosy drug.

Some immunosuppressed patients can get unusual skin infections from Malassezia, which can be treated with antifungal medication.

A woman with EMS showed unusual skin mucinosis without the typical hard skin syndrome, suggesting EMS can cause skin mucinosis.

Nail changes from immunotherapy can be managed without stopping cancer treatment.

Tofacitinib successfully treated hair loss in a Crohn's disease patient who previously used adalimumab.

More research is needed to understand and manage angioedema in pregnant women with lupus.

RAPK is a rare skin disorder with pigmented spots, mainly on hands and feet, starting in youth.

Skin pigmentation increases in CRPS-affected areas and improves with symptom relief.

Adding dupilumab led to almost complete hair regrowth in a patient with alopecia areata who only partially responded to baricitinib.